login

Clinical trial of mebendazole, a broad-spectrum anthelminthic.

BMJPublished 10 May 1975Open access
J. G. P. Hutchison, N. M. Johnston, M V Plevey, Irene Thangkhiew, C Aidney
Citations37
View PDF

TL;DR

The drug was well tolerated and with its broad activity should be very useful in treating those with multiple infestations.

Abstract

Eighty-five children aged 5-14 years who were infested with worms were treated with mebendazole 100 mg twice daily for three days. The percentage cure rates were ascaris 100%, trichuris 94%, hookworm 82%, and hymenolepis 39%. The drug was well tolerated and with its broad activity should be very useful in treating those with multiple infestations.